年別の研究成果
年別の研究成果
- 11 件
検索結果
-
2022
Adapted whole-body surveillance for von Hippel–Lindau-associated tumors in 3p deletion syndrome with VHL deletion: A case report
Morisawa, K., Sato, T., Shimoyamada, M., Mizuno, R., Ohashi, H., Watanabe-Hisazumi, H., Takeshima, K., Kojima, A., Sato, S., Hasegawa, T. & Takahashi, T., 2022 11月, In: Pediatric Blood and Cancer. 69, 11, e29732.研究成果: Letter › 査読
-
Germline BRCA2 mutation in a case of aggressive prostate cancer accompanied by spinal bulbar muscular atrophy
Hongo, H., Kosaka, T., Hayashi, H., Nakamura, K., Nishihara, H., Mikami, S., Beltran, H. & Oya, M., 2022 1月 1, In: Asian Journal of Andrology. 24, 1, p. 116-118 3 p.研究成果: Letter › 査読
Open Access2 被引用数 (Scopus) -
Potential benefits of rapid genetic testing for germline WT1 in infants with bilateral renal tumors: A case report
Yoshikawa, H., Sato, T., Ishikawa, T., Ito, J., Yamazaki, F., Shima, H., Honda, M., Shibata, H., Ishii, T., Asanuma, H., Shimada, H. & Hasegawa, T., 2022 2月, In: Pediatric Blood and Cancer. 69, 2, e29368.研究成果: Letter › 査読
-
Reply to Fredrik Liedberg, Johan Abrahamsson, and Johannes Bobjer's Letter to the Editor re: Keisuke Shigeta, Kazuhiro Matsumoto, Koichiro Ogihara, et al. Does Neoadjuvant Chemotherapy have Therapeutic Benefit for Node-positive Upper Tract Urothelial Carcinoma? Results of a Multi-center Cohort Study. Urol Oncol. In press. https://doi.org/10.1016/j.urolonc.2021.07.029: A Plea for Uniform Terminology for Patients with Urothelial Carcinoma Treated with Chemotherapy Before Consolidative Surgery with Curative Intent: Induction Versus Neoadjuvant Chemotherapy: Need for Debate on the Optimized Treatment Strategy for Node-positive Upper Tract Urothelial Carcinoma
Shigeta, K., Matsumoto, K. & Oya, M., 2022 1月, In: European Urology. 81, 1, p. e20-e21研究成果: Letter › 査読
-
2016
Syndrome of inappropriate antidiuretic hormone secretion in a patient with castration-resistant prostate cancer treated with enzalutamide
Yanai, Y., Matsumoto, K., Niwa, N., Kosaka, T., Kikuchi, E., Miyajima, A., Ito, H. & Oya, M., 2016 1月 1, In: Acta Oncologica. 55, 3, p. 399-400 2 p.研究成果: Letter › 査読
1 被引用数 (Scopus) -
2014
Activity of axitinib in patients with metastatic renal cell carcinoma previously treated with both vascular endothelial growth factor receptor tyrosine-kinase inhibitor and mammalian target of rapamycin inhibitor
Mizuno, R., Miyajima, A. & Oya, M., 2014 7月, In: International Journal of Urology. 21, 7, p. 740 1 p.研究成果: Letter › 査読
1 被引用数 (Scopus) -
20121 被引用数 (Scopus)
-
2011
Reply by the authors
Kikuchi, E. & Matsumoto, K., 2011 1月 1, In: Urology. 77, 1, p. 252-253 2 p.研究成果: Letter › 査読
-
Response
Jinzaki, M., Matsumoto, K., Tanami, Y., Ueno, A., Yamada, M. & Kuribayashi, S., 2011 9月 1, In: Radiology. 260, 3, 1 p.研究成果: Letter › 査読
-
2008
Carcinoma in situ of the Upper Urinary Tract Treated with Radical Nephroureterectomy - Results from a Multicenter Study
Karam, J. A., Margulis, V., Montorsi, F., Karakiewicz, P. I., Lotan, Y., Kikuchi, E., Weizer, A., Zigeuner, R., Bolenz, C. & Shariat, S. F., 2008 10月 1, In: European Urology. 54, 4, p. 961-963 3 p.研究成果: Letter › 査読
14 被引用数 (Scopus) -
Pharmacokinetics of cisplatin and methotrexate after M-VAC chemotherapy for advanced urothelial cancer in hemodialysis patients
Matsumoto, K., 2008 10月, In: International Journal of Urology. 15, 10, p. 949-950 2 p.研究成果: Letter › 査読
9 被引用数 (Scopus)